RHYTHM PHARMACEUTICALS, INC. Long-Term Debt
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Long-Term Debt of $93.40 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-04
- 2026-06-30: Long-term Debt, Excluding Current Maturities $93.40M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $98.34M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $100.89M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $103.41M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $93.40M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $98.34M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $100.89M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $103.41M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $106.01M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $107.93M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $108.27M 10-K · filed 2026-02-26 |
| 2023-12-31 | $106.14M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |